-
-
In this issue: Clopidogrel and proton pump inhibitors; adverse events with tamsulosin after cataract surgery; new guidelines for persistent pain in the elderly; and FDA Actions.
-
Numerous studies have demonstrated the benefit of an early invasive strategy in patients presenting with non-ST elevation acute coronary syndromes (ACS).
-
The role of intensive antiplatelet therapy for prevention of vascular events in patients with atrial fibrillation remains controversial.
-
This report from Garza et al describes improved outcomes in out-of-hospital cardiac arrest victims after a cardiopulmonary resuscitation (CPR) protocol change by the emergency medical services (EMS) system in Kansas City, MO.
-
The differential diagnosis of acute chest pain includes three entities that can be lethal if missed: myocardial infarction (MI), pulmonary embolus, and aortic dissection.
-
Six years ago, Wild and Law, two British physicians, proposed that a single pill with multiple active components could profoundly reduce cardiac risk (CV).
-
Although it is well known that incessant atrial tachyarrhythmias can cause left ventricular (LV) dysfunction, little is known about focal atrial tachycardia and LV dysfunction.
-
Family planning clinicians have become familiar with providing Gardasil (Merck & Co.), the quadrivalent vaccine for human papillomavirus (HPV), to young women. Will their practice extend to include young men if the vaccine is approved by the Food and Drug Administration (FDA)?
-
What if a vaginal ring could deliver protection against unplanned pregnancy and HIV infection? Scientists are testing a ring loaded with multiple antiviral drugs to prevent HIV infection, and they also are weighing its use in pregnancy prevention.
